跳至主要内容
临床试验/RBR-37jpt3
RBR-37jpt3已完成4 期

A Randomized single-blinded, parallel group and unicentric Phase IV Clinical Study of non-inferiority, comparing the drug Lysine Clonixinate (Dolamin®) and Ibuprofen (Advil®) in reducing acute pain related to tendinopathy in patients

CREB-Centro de Reumatologia e Ortopedia Botafogo Sociedade Simples LTDA0 个研究点开始时间: 2014年9月16日最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
18Y 至 65Y(—)

入选标准

  • Volunteers be carrying from acute pain related to tendinopathy (tendinitis, tenosynovitis and bursitis of the shoulders, wrists / hands, knees and ankles / feet and require immobilization;
  • age between 18 and 65 (sixty five) years; Indicate, in max, grade 7 in the Visual Analogue Scale (VAS) of pain; Having signed and dated the 'Informed of Consent Form' (ICF) specified for this study, prior to any participation in procedures related to it.

排除标准

  • None of the patients included in this study should be carrying from acute pain related to tendinopathy at the hip; having a history of asthma or bronchospasm, nasal polyps, allergic reactions and / or induced by acetylsalicylic acid (aspirin) or other anti-inflammatory drugs; history of gastrointestinal bleeding due to the use of NSAIDs; is receiving treatment with other anti-inflammatory drugs, corticosteroids or analgesics; Is receiving treatment with oral anticoagulants, ticlopidine, heparin and thrombolytics; be pregnant and / or lactating; be hypersensitive (allergic) to any of the components of the formula;
  • 8. Be a regular user of alcohol and barbiturates; have hepatic or renal impairment.

研究者

发起方
CREB-Centro de Reumatologia e Ortopedia Botafogo Sociedade Simples LTDA

相似试验